QNET Launches Ayurvedic Diabetes Management Supplement in India
product formulated with a combination of different herb and plant extracts that have been proven in Ayurveda to be effective in blood sugar management. Diabetes Mellitus is one of the major killers of the modern world. According to WHO the number of people living with diabetes has nearly quadrupled since 1980 to 422 million adults, most of who live in developing countries including India.
Approximately 65 million Indians are living with diabetes currently, compared to 50.8 million in 2010. Diabetes has been discussed at length in the ancient texts of Ayurveda and is referred to as Madhumeha, a palliative disease that cannot be completely cured, but can be controlled by food and medicine. QNET has partnered with an Ayurveda research and development lab in the state of Uttar Pradesh to develop Nutriplus Nature Diabahealth, exclusively for its customers in India. The product’s composition includes a proprietary blend of ten ingredients.
The key ingredient, Kino (Malabar kino), contains a bioactive compound called ‘Epicatechin’ which has been proven to be a natural insulin mimetic (NAISUMI). In addition, ingredients such as Karela (Bitter gourd) and Jambul (Indian blackberry) have been clinically proven to aid the absorption of sugar from blood to cells, leading to better management of blood sugar levels. DiabaHealth is formulated using Bioplantex Technology which involves a one-step extraction process of bioactive compounds to ensure minimum deterioration of the extracts, and results in higher levels of bioactivity and yield of the key molecules. DiabaHealth is manufactured in India in a WHO GMP, ISO Certified and HACCP certified manufacturing facility.
UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by recent snow and ice storms in North Carolina Support includes assisting health plan participants who may need to make alternate arrangements to access care and early prescription refills, as well as offering a free emotional-support line to help
Beil² - Die PR-Strategen GmbH,
Gibraltar, Jan 18, 2018 (GLOBE NEWSWIRE) -- Olympus Labs is quickly becoming an emerging global leader in the cryptocurrency-based financial product space, and on the heels of a successful token sale, Olympus is partnering with Seoul-based corporation Metaps Plus, a leading Korean fintech company and mobile marketing platform developer This news comes shortly after the company announced OKEx,
Beerse, Belgien - Janssen Pharmaceutical Companies of Johnson & Johnson gibt die Ergebnisse einer aktuellen, an der Versorgungspraxis orientierten Studie mit nahezu 30 000 Personen bekannt, die den Nutzen von Depot-Antipsychotika (LATs, long-acting antipsychotics) für eine Verringerung
(RTTNews) - Amgen (AMGN) and Allergan plc (AGN) announced Thursday that the European Commission has granted marketing authorization for MVASI (biosimilar bevacizumab) MVASI is the first biosimilar bevacizumab approved by the EC and is approved for the treatment of certain types of cancers
Marketagent com und die Change-Marketing-Agentur falknereiss haben Experten dazu befragt, wie die Branche im Jahr 2027 aussehen wird
Mit dem spannenden und hochaktuellen Thema „Influencer Marketing – Quo vadis?“ startete der Marketing Club (MCÖ) am 15
Wenig hilfreich, was Google da PR mäßig macht Spectre ist ein CPU HW-Design Problem
Das PR-Desaster um ein schwarzes Kindermodel ist nur das jüngste vieler Probleme, die H&M plagen
Die 35-jährige Niederösterreicherin Cornelia Spitzer leitet fortan die Geschicke des IT-Services-Anbieter im Bereich Marketing Operations